An updated draft of China’s Amended Personal Information Security Specification (Amended PIS Specification) and proposed new amendments to the privacy specification for mobile apps (App Privacy Specification) were published this week, alongside brand new draft
Continue Reading
As breakthroughs in artificial intelligence and related technologies gallop forward at what feels like a frenzied pace, lawmakers in Congress and officials from a wide range of federal regulatory agencies are increasingly focused on enacting
Continue Reading
By Margo H. K. Tank, David Whitaker, Andrew Grant and Liz Caires
A fact of business today is that customers – both consumers and other businesses – and
Continue Reading
By Edward J. McAndrew and Jeff DeGroot
Over the past three years, the “business email compromise” has become one of the most common, vexing, and financially injurious forms of cybercrime. On any given day, companies
Continue Reading
By: Margo H. K. Tank, Mark F. Radcliffe Michael D. Hamilton
To remain competitive, companies find themselves increasing their efforts to digitally transform their businesses by developing new offerings based on emerging technologies and integrating
Continue Reading
Read our EU-Greek practice’s guide to anti-trust litigation in Greece, published by Chambers and Partners, which introduces future trends in the anti-trust enforcement process that is now an integral part of the legal system in
Continue Reading
By Richard Chesley and Oksana Koltko Rosaluk
“We have done a lot to democratize free, unlimited communications for billions of people. We want to help do the same for digital currency and financial services .
Continue Reading
Artificial intelligence, virtual reality, augmented reality, digital assets, and blockchain are among the new technologies we discuss in this issue, each of them requiring regular review and analysis of current laws and sometimes new laws
Continue Reading
By Stefanie Fogel and Maggie Craig
When the 2018 Farm Bill removed hemp from the definition of marijuana – and thus from the list of Schedule I drugs under the Controlled Substance Act (CSA) –
Continue Reading
The Dutch government has published its tax proposals for 2020 and beyond. What does this means for multinational companies? Jian-Cheng Ku, Daan Arends and Rhys Bane explain that the plan mainly aims to implement
Continue Reading
